AbbVie
ABBV
#26
Rank
NZ$691.65 B
Marketcap
NZ$391.34
Share price
-1.15%
Change (1 day)
34.26%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Stock price history for AbbVie (ABBV)

Highest end of day price: NZ$423.02 NZD on 2025-10-01

Lowest end of day price: NZ$34.97 NZD on 2013-01-08

Stock price history of AbbVie from 2013 to 2025

Annual Stock Price Performance

Year Performance
2025 29.46%
2024 15.25%
2023-0.71%
2022 23.99%
2021 34.61%
2020 26.28%
2019 4.83%
2018-2.67%
2017 60.61%
2016 12.90%
2015-7.14%
2014 29.96%
2013 56.38%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$45.06 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$90.27 0.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1,749-0.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$571.04-3.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$209.83-1.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$313.83-0.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$83.80-0.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$156.10 0.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$269.19 0.84%๐Ÿ‡บ๐Ÿ‡ธ USA